breast cancer
Conditions
Interventions
Case series:sentinel lymph node biopsy
Sponsors
Cancer Hospital, Chinese Academy of Medical Sciences
Eligibility
Sex/Gender
Female
Age
27 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Female patient (2) The seventh edition of the AJCC Cancer Staging Manual belongs to patients with stage II-III invasive breast cancer; (2) No evidence of distant metastasis at baseline; (3) The core niddle biopsy (CNB) was used to determine the pathological type and the fine niddle aspiration (FNA) was used to confirm the axillary lymph node metastasis. (4) Taxanes, anthracyclines, platinum and other drugs neoadjuvant chemotherapy over 6 cycles (5) After neoadjuvant chemotherapy, both breast and axillary ultrasonography and MRI were performed to evaluate the axillary lymph node metastasis and surgical treatment in our hospital (according to the tumor size, location, patients' wishes and other factors, choose breast-conserving or modified radical cure); (6) The above first diagnosis, neoadjuvant chemotherapy, imaging acquisition, biopsy, imaging examination, surgical treatment and pathological examination were completed in our hospital.
Exclusion criteria
Exclusion criteria: (1) drugs such as taxanes, anthracyclines, platinum and other drugs less than 6 cycles of neoadjuvant chemotherapy, or midway replacement chemotherapy; (2) imaging or medical history information is not included in the group; (3) distant metastasis signs have appeared; (4) patients due to severe heart and lung dysfunction, can not tolerate surgery; (5) The patient withdraw from the study halfway through other reasons unrelated to the project for any physical or social reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| identification rate; | — |
Countries
China
Contacts
Public ContactXin Wang
Cancer Hospital, Chinese Academy of Medical Sciences
Outcome results
None listed